Elastography Imaging Market
Report ID: SQMIG35D2373
Report ID: SQMIG35D2373
sales@skyquestt.com
USA +1 351-333-4748
Report ID:
SQMIG35D2373 |
Region:
Global |
Published Date: January, 2026
Pages:
179
|Tables:
34
|Figures:
69
Global Elastography Imaging Market size was valued at USD 2.91 Billion in 2024 and is poised to grow from USD 3.14 Billion in 2025 to USD 5.72 Billion by 2033, growing at a CAGR of 7.8% during the forecast period (2026–2033).
The global elastography imaging market growth is fuelled by increased demand for non-invasive diagnostic approaches, growing rates of chronic liver disease and breast cancer, and advances in elastography in ultrasound and MRI modes. Moreover, with growing public acuity to early detect diseases and favorable related government act contributions, the market will foster growth. Further, the fast adoption of elastography services in developing economies and advances in the development of portable imaging systems are helping. General players in the market are putting money toward R&D to enhance the imaging accuracy and amplified use in clinic and practice. Taken together, the aforementioned will grow the elastography market and lens its utilization in diagnostic imaging overall.
What Makes AI Integration Crucial for Elastography Imaging Market?
AI integration is a perplexing issue for elastography imaging market, as this will improve and cement the accuracy of diagnoses with AI, image analysis can easily be automated, and human error can be reduced. Machine learning algorithms may also enhance the quantification of tissue stiffness, leading to the advanced and accurate early detection of diseases such as liver fibrosis and breast cancer. AI-based tools can improve workflow efficiencies by reducing the occurrences of diagnostic bottlenecks, and can effectively assist radiologists in decision-support capabilities. Most importantly, AI allows for predictive analytics that will go into building an increasingly personalized treatment plan for patients. With healthcare continuing to move towards precision medicine to ensure value-based care, AI-enhanced elastography is becoming critical and will perpetuate the growth of the market. AI-supported elastography will allow for advanced, dependable, and faster diagnostic solutions to better serve the patients of the future.
Market snapshot - 2026-2033
Global Market Size
USD 860 Million
Largest Segment
Magnetic Resonance
Fastest Growth
Growth Rate
9.3% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global Elastography Imaging Market is segmented by Technology, Application, End-User and region. Based on Technology, the market is segmented into Ultrasound Elastography and Magnetic Resonance Elastography (MRE). Based on Application, the market is segmented into General Imaging / Radiology, Hepatology (Liver / Fibrosis), Breast Imaging, Cardiology, Orthopedic & Musculoskeletal and Urology / Vascular / Others. Based on End-User, the market is segmented into Hospitals, Diagnostic Imaging Centres and Ambulatory Surgical Centres (ASCs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
As per the global elastography imaging market analysis, Ultrasound accounted for the major share of the market due to cost effectiveness, rapid outcomes, and better accessibility to patients. Ultrasound elastography is replacing standard ultrasound systems in evaluating organs and suggesting a biopsy because it uses ultrasound to evaluate stiffness in tissues instantaneously without any invasive measures. The transportable feature and ease of use of ultrasound elastography further drives the usage and clinical applicability by healthcare professionals in hospital settings or outpatient divisions because it is a desirable imaging technique for liver fibrosis and breast lesion detection. The advancement of medical imaging and ultrasound elastography with non-invasive diagnostic images cements ultrasound's leading role in continuing to lead the elastography imaging market.
Whereas the demand for the MRI segment is expected to show lucrative growth during the forecast period. The utilization of magnetic resonance imaging (MRI) is gaining prominence as the preferred method for diagnosing liver diseases. The increasing adoption of MRE can be attributed to its precise results and the painless nature of the procedure, which collectively contribute to the growth of this segment. MRE proves to be an effective tool for diagnosing advanced liver fibrosis, aiding in gauging the severity of liver disease and assisting in determining the appropriate course of treatment.
Based on the global elastography imaging market forecast, the general imaging segment accounted for the largest revenue share of due to its widespread utility across various medical disciplines. Elastography, as a non-invasive technique for assessing tissue stiffness, finds extensive use in general imaging applications, including liver disease diagnosis, cancer detection, and musculoskeletal assessments. Its versatility allows healthcare professionals to obtain valuable information in routine clinical settings, contributing to its dominance as a go-to diagnostic tool.
The breast segment is expected to have the largest global elastography imaging market share. The segment is estimated to register the fastest CAGR over the forecast period due to the increasing demand for non-invasive and accurate diagnostic tools in breast health assessment. Elastography imaging offers a valuable adjunct to traditional breast imaging methods by providing insights into tissue stiffness, aiding in the early detection and characterization of breast lesions.
To get detailed segments analysis, Request a Free Sample Report
North America held the largest elastography imaging market share, driven by the presence of a large number of global players in the region. Moreover, increasing efforts by manufacturers for commercialization and growing importance among end users for the use of these systems in different countries is driving the regional market.
The U.S. elastography imaging market accounted for the largest share in North American region. The U.S. benefits from a robust ecosystem of healthcare institutions, key market players, and research facilities, facilitating the rapid integration of elastography imaging into clinical practices. In addition, a favorable reimbursement landscape and a proactive approach to early disease detection contribute to the widespread acceptance in various medical applications, further solidifying the U.S.'s leading position in the North American region.
The Canada elastography imaging market is developing in response to an increased demand for non-invasive diagnostics, particularly in liver fibrosis assessment and breast cancer diagnosis. Innovations and advances in ultrasound elastography and MRI elastography devices are growing. Government health service interventions, along with their assimilation into hospital workflows and procedures will help facilitate this growth, along with developing technologies with increased focus on early diagnosis of disease. This can position Canada in a leading position in North America.
The Asia Pacific elastography imaging market is expected to grow at the fastest rate during the forecast period. Increasing geriatric population, improving healthcare services, and rapid economic growth are factors expected to drive the regional market. Growth in Asia Pacific is majorly contributed by economies such as India, Japan, and China due to speedy expansion of healthcare facilities. Furthermore, increasing awareness among the public concerning therapeutic potential of ultrasound technologies and accurate and speedy results provided by these devices is contributing to the regional market.
The Japan elastography imaging market is expected to witness significant growth, driven by the country’s rapidly aging population, increasing prevalence of chronic liver diseases, and strong focus on technological innovation in medical imaging. Japan’s well-established healthcare infrastructure and high adoption rate of advanced diagnostic tools have facilitated the integration of elastography into routine medical practice, particularly in hepatology, oncology, and musculoskeletal imaging.
China elastography imaging market accounted for the largest share in the Asia Pacific region. The country's large population and rising healthcare awareness drive the demand for advanced diagnostic tools, including elastography imaging, for conditions such as liver disease and cancer. Moreover, the Chinese government's initiatives to modernize healthcare and promote research and development contribute to the widespread adoption of innovative medical imaging technologies.
The Europe elastography imaging market is expected to grow owing to the increasing awareness of non-invasive diagnostic techniques, advancements in imaging technology, and a rising prevalence of chronic diseases such as liver fibrosis, cancer, and musculoskeletal disorders. The region's well-established healthcare infrastructure, coupled with strong government support for early disease detection and preventive healthcare, has facilitated the widespread adoption of elastography.
The Germany imaging elastography market is driven by the country’s advanced healthcare infrastructure, strong research and development ecosystem, and increasing prevalence of chronic diseases such as liver fibrosis and cancer. With a high adoption rate of innovative medical imaging technologies, German hospitals and diagnostic centers are increasingly incorporating elastography into routine clinical practice. In addition, the country’s emphasis on early disease detection and preventive healthcare, supported by government initiatives and favorable reimbursement policies, is further accelerating market expansion.
The market for elastography imaging in France continues to rise in demand due to increasing demand for non-invasive diagnostics, especially in the assessment of liver/ breast disease. Demand is being fueled due to the investment of the government in healthcare and the adoption of advanced ultrasound/ MRI elastography approaches in hospitals. France continues to have a solid medical imaging landscape and focus on early diagnosis making it a significant European market for elastography technologies.
The UK elastography imaging market is expected to grow over the forecast period, driven by increasing adoption of advanced diagnostic imaging technologies and a strong emphasis on early disease detection. The rising prevalence of liver disorders, particularly due to alcohol-related liver disease and non-alcoholic fatty liver disease (NAFLD), has heightened the demand for non-invasive assessment tools like elastography. In addition, the National Health Service (NHS) and private healthcare providers are investing in cutting-edge imaging solutions to enhance patient outcomes and reduce the need for invasive biopsies.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Rising incidence of chronic diseases & breast cancer
Shift toward minimally invasive surgeries
Unfavourable reimbursement frameworks
High capital cost of MRI-based systems
Request Free Customization of this report to help us to meet your business objectives.
The global elastography imaging market has a competitive landscape with significant market share of Siemens Healthineers, GE Healthcare, Philips, Canon Medical Systems, and Hitachi. Competitors in this market utilize new technologies and strategic partnerships to gain market share. Companies in this market are spending on AI integration in elastography, portable systems, and further advances in ultrasound/MRI elastography systems to increase diagnostic accuracy. Mid-sized manufacturers have leveraged cost-effective solutions to capture market share, particularly in emerging markets. The market continues to see increased competition via mergers, product launches and geographic expansions, with North America and Europe being the prominent adopters currently. In addition, new players are introducing elastography to niche applications like musculoskeletal and thyroid imaging, while the dominant companies in liver and breast cancer diagnostics maintain their competitiveness through integrated solutions and distribution networks.
EchoNous (2015): EchoNous has emerged as a disruptive force in elastography imaging with its innovative Kosmos platform - a handheld, AI-integrated ultrasound system featuring shear wave elastography capabilities. The Seattle-based startup's compact device delivers hospital-grade diagnostic accuracy for liver fibrosis and thyroid assessments at the point-of-care, particularly valuable for rural clinics and emergency settings.
Elastica Imaging (2020): Elastica Imaging is revolutionizing musculoskeletal diagnostics through its advanced real-time strain elastography technology. The Helsinki-based startup has developed a specialized platform that enables precise assessment of soft tissue injuries, particularly targeting tendon pathologies and sports-related musculoskeletal disorders.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the elastography imaging market is undergoing transformative growth, fueled by the convergence of precision diagnostics and AI-driven automation. Key expansion drivers include the surging demand for non-invasive liver fibrosis and breast cancer screening, with elastography replacing 30% of biopsy procedures in developed markets. Breakthroughs in AI-powered quantification algorithms are reducing diagnostic variability by 50%, while shear wave elastography (SWE) systems now deliver real-time, operator-independent results.
Strategic partnerships between medtech giants and AI startups are accelerating the commercialization of portable elastography devices, expanding access in rural and point-of-care settings. Regulatory tailwinds, such as FDA clearances for AI-enhanced ultrasound elastography, further propel adoption. The market also benefits from IoT-enabled imaging platforms that integrate elastography data with EHRs for predictive analytics in chronic disease management. SkyQuest projects a surge in multimodal elastography (MRI + ultrasound) for comprehensive tissue characterization, with Asia-Pacific emerging as the fastest-growing region due to rising healthcare digitization. This fusion of advanced imaging, AI, and decentralized diagnostics positions elastography as a cornerstone of next-generation radiology.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 2.91 Billion |
| Market size value in 2033 | USD 5.72 Billion |
| Growth Rate | 7.8% |
| Base year | 2024 |
| Forecast period | 2026-2033 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Elastography Imaging Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Elastography Imaging Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Elastography Imaging Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Elastography Imaging Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
